Leiva, Orly http://orcid.org/0000-0002-3006-6380
Ng, Seng Kah
Matsuura, Shinobu
Chitalia, Vipul
Lucero, Hector
Findlay, Alison
Turner, Craig
Jarolimek, Wolfgang
Ravid, Katya
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01HL136363)
Article History
Received: 25 April 2019
Revised: 18 September 2019
Accepted: 23 September 2019
First Online: 21 October 2019
Compliance with ethical standards
:
: The authors declare that they have no conflict of interest. The authors affiliated with Pharmaxis synthesized and characterized the inhibitors and tested their efficacy in terms of inhibition of LOX in vivo, but were not involved in performing the experiments related to evaluation of fibrosis burden, and in interpretation of the results.